New treatments for chronic obstructive pulmonary disease.
No currently available drugs prevent the progression of chronic obstructive pulmonary disease, one of the leading causes of morbidity and mortality worldwide. Several new drugs are now in development that may affect the underlying inflammatory and destructive processes in this increasingly common disease.
Barnes
P J
PJ
National Heart and Lung Institute, Imperial College School of Medicine, London, UK. p.j.barnes@ic.ac.uk
D000280:Administration, Inhalation; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D018836:Inflammation Mediators / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000628:therapy*; D016540:Smoking Cessation
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D018836:Inflammation Mediators; D011480:Protease Inhibitors